| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |